Mandorfer, Mattias
Hernández-Gea, Virginia
Reiberger, Thomas
García-Pagán, Juan Carlos
Funding for this research was provided by:
Medical University of Vienna
Article History
First Online: 2 May 2019
Compliance with Ethical Standards
:
: Mattias Mandorfer served as a speaker and/or consultant and/or advisory board member for AbbVie, Bristol-Myers Squibb, Gilead, and W. L. Gore & Associates and received travel support from AbbVie, Bristol-Myers Squibb, and Gilead. Virginia Hernández-Gea served as a speaker for W. L. Gore & Associates. Thomas Reiberger served as a speaker and/or consultant and/or advisory board member for AbbVie, Bayer, Boehringer Ingelheim, Gilead, Intercept, MSD, Roche, Siemens, and W. L. Gore & Associates and received grants/research support from AbbVie, Boehringer Ingelheim, Gilead, MSD, Philips, and W. L. Gore & Associates as well as travel support from Boehringer Ingelheim, Gilead, and Roche. Juan Carlos García-Pagán served as a speaker and/or advisory board member for Cook and W. L. Gore & Associates and received grants/research support from Conatus, Exalenz, Novartis, and Theravance.
: This article does not contain any studies with human or animal subjects performed by any of the authors.